SomaGenics Granted New Patents for RNA Detection and RNA-based Therapeutics Technologies

December 1, 2016 Leave a comment 3,638 Views

SomaGenics, an RNA-focused biotechnology company, announced expansion of its intellectual property portfolio with issue of two new patents for its RNA analysis technologies (miR-ID® and RealSeq®) and European patent protection for its therapeutic short synthetic hairpin RNA (sshRNA) agents. MiR-ID®, ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: miR-Direct

SomaGenics Granted New Patents for RNA Detection and RNA-based Therapeutics Technologies

PIE-seq – identifying RNA-binding protein targets by dual RNA-deaminase editing and sequencing

The relevance of single-cell analysis approaches for the characterization of amniotic fluid cells

Space-time scRNA-seq of healing skin wounds

Spatial RNA sequencing reveals where atherosclerotic plaques rupture can lead to preventive treatments

New algorithm six times more reliable at predicting defective RNA

Alternative splicing analysis benchmark with DICAST

The Curated Cancer Cell Atlas – a comprehensive pan-cancer single-cell RNA-sequencing dataset